Who are we?

The Scientific Advisory Committee

The Scientific Advisory Committee

The Scientific Advisory Committee

The Scientific Advisory Committee This committee has for vocation to provide expert opinions to Imagine for Margo’s Board of Directors about research projects to be financed. Representatives will include professors and eminent researchers in oncology at the French and international levels. This committee is currently being constituted.

Organization and Teams

Organization and Teams

Organization and Teams

LE COMITÉ D’ADMINISTRATION PERMANENTS Sabrina Palanza : Assistante de direction, évènements et bénévoles. Isabelle Delarue : Chargée de projets évènementiels  Aude Bechaux : Aide à la trésorerie et administratif Delphine Van Heeswyck : Responsable communication Eva Denjean : Chef de projet communication BÉNÉVOLES RÉFÉRENTS Frédéric Lemos : programme de recherche, colloque annuel sur la recherche […]

Documents and key figures

Documents and key figures

Documents and key figures

BUSINESS PURPOSE AND STATEMENTS The association « Imagine for Margo – Children without Cancer », created on November 26th, 2011, is a recognized public interest organization intended to lead awareness and fund raise activities for European research in support of specific, innovative and more effective treatments for childhood cancer. In addition, it provides support to […]

Origin

Origin

Origin

Margaux died on June 7th, 2010 of an aggressive brain tumor. She was 14 years old. For 16 months, shefought hercancer with remarkable courage. She keptherradiant smile and remained more concernedabout others than she was about herself. In March 2009, Margauxinitiated a fund raisingcampaign which generated an immense outpouring of generosity and solidarity.  103 000 […]

Lobbying

Lobbying

Lobbying

Even though pediatric cancers are not the same as those in adults, only 2 % of cancer research expenditures are allocated to  pediatrics and more than half of current treatments are « off label », meaning that they are not officially authorized for use on children. It is therefore essential to accelerate development of specific treatments and […]

Our main missions

Our main missions

Our main missions

Our main missions Childhood cancer is the leading cause of death by disease in children with 1 child in 440 diagnosed before the age of 15.  These numbers have been increasing by 1% to 2% a year for the past 30 years. With 60 different types, these cancers remain “rare diseases” so research for new treatments is […]